Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
3-CYANO-BENZAMIDE REF: IN-DA00BXOHCAS: 3441-01-8 | 97% | To inquire | Wed 20 Nov 24 | |
3-cyanobenzamide REF: 10-F313129CAS: 3441-01-8 | 95.0% | 56.00 €~2,916.00 € | Mon 25 Nov 24 | |
m-Cyanobenzamide REF: 54-OR946455CAS: 3441-01-8 | 96% | 38.00 €~1,028.00 € | Wed 27 Nov 24 | |
3-Cyanobenzamide REF: 3D-FC55034CAS: 3441-01-8 | Min. 90% | 136.00 €~1,160.00 € | Tue 03 Dec 24 | |
3-Cyanobenzamide REF: 3D-DAA44101CAS: 3441-01-8 | Min. 95% | - - - | Discontinued product |
3-CYANO-BENZAMIDE
CAS:3441-01-8
Formula:
C8H6N2O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
146.1460
Ref: IN-DA00BXOH
1g | 51.00 € | ||
5g | 104.00 € | ||
25g | 193.00 € | ||
500g | To inquire | ||
100mg | 27.00 € | ||
250mg | 31.00 € |
Estimated delivery in United States, on Wednesday 20 Nov 2024
Ref: 10-F313129
1g | 56.00 € | ||
5g | 72.00 € | ||
10g | 131.00 € | ||
25g | 301.00 € | ||
100g | 895.00 € | ||
500g | 2,916.00 € |
Estimated delivery in United States, on Monday 25 Nov 2024
Ref: 54-OR946455
1g | 69.00 € | ||
5g | 161.00 € | ||
25g | 574.00 € | ||
250mg | 38.00 € |
Estimated delivery in United States, on Wednesday 27 Nov 2024
3-Cyanobenzamide
CAS:3441-01-8
3-Cyanobenzamide is an organic compound with the formula CHC(N)NH. It is a white crystalline solid …
Formula:
C8H6N2O
Purity:
Min. 90%
Molecular weight:
146.15 g/mol
Ref: 3D-FC55034
1g | 136.00 € | ||
2g | 198.00 € | ||
5g | 364.00 € | ||
10g | 582.00 € | ||
25g | 1,160.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
3-Cyanobenzamide
CAS:3441-01-8
Please enquire for more information about 3-Cyanobenzamide including the price, delivery time and more detailed …
Formula:
C8H6N2O
Purity:
Min. 95%
Molecular weight:
146.15 g/mol
Ref: 3D-DAA44101
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information | |
2500mg | Discontinued | Request information |